* Blue Water Biotech Inc BWV.OQ BWV.O is expected
to report
results on September 28 (estimated).
*
* Refinitiv's mean analyst estimate for Blue Water Biotech
Inc is
for a loss of 15 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Blue Water
Biotech Inc is $9, above its last closing price of $0.53.
This summary was machine generated September 26 at 22:34 GMT.
All figures in US dollars unless otherwise stated